Release of acetylcholine by Hon-Chi to raise insulin secretion in Wistar rats

Neuroscience Letters

Volumn 404, Issue 1-2, 2006, Pages 117-121

  Chen, Chang Chih ^a   Liu, I Min ^b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAJEN UNIVERSITY   (Taiwan)

Author keywords

Acetylcholine; Hon Chi; Insulin; Muscarinic M3 receptors; Wistar rats

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; GANGLION BLOCKING AGENT; HEMICHOLINIUM 3; HEXAMETHONIUM BROMIDE; HON CHI; INSULIN; MUSCARINIC AGENT; MUSCARINIC M3 RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PENTOLONIUM TARTRATE; PHYSOSTIGMINE; UNCLASSIFIED DRUG; VESAMICOL; VESICULAR ACETYLCHOLINE TRANSPORTER;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; CHOLINE UPTAKE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; FOOD; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NERVE ENDING; NERVE STIMULATION; NONHUMAN; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; SYNAPSE;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; DRUGS, CHINESE HERBAL; INSULIN; MALE; NERVE ENDINGS; PHYSOSTIGMINE; RATS; RATS, WISTAR;

EID: 33745879807     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.05.024     Document Type: Article

References (21)

1. Anderson D.C., King S.C., and Parsons S.M. Pharmacological characterization of the acetylcholine transport system in purified Torpedo electric organ synaptic vesicles. Mol. Pharmacol. 24 (1983) 48-54
2. Aquilonius S.M., and Hartvig P. Clinical pharmacokinetics of cholinesterase inhibitors. Clin. Pharmacokinet. 11 (1986) 236-249
3. Barlow R.B., McMillen L.S., and Veale M.A. The use of 4-diphenylacetoxy-N-(2-chloroethyl)-piperidine (4-DAMP mustard) for estimating the apparent affinities of some agonists acting at muscarinic receptors in guinea-pig ileum. Br. J. Pharmacol. 102 (1991) 657-662
4. 3 muscarinic receptors. Am. J. Physiol. 268 (1995) E336-E442
5. Duttaroy A., Zimliki C.L., Gautam D., Cui Y., Mears D., and Wess J. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice. Diabetes 53 (2004) 1714-1720
6. Fischbach G.D., Frank E., Jessell T.M., Rubin L.L., and Schuetze S.M. Accumulation of acetylcholine receptors and acetylcholinesterase at newly formed nerve-muscle synapses. Pharmacol. Rev. 30 (1978) 411-428
7. Free R.B., and McKay D.B. Receptor protection studies to characterize neuronal nicotinic receptors: tubocurarine prevents alkylation of adrenal nicotinic receptors. Brain Res. 891 (2001) 176-184
8. Gilon P., and Henquin J.C. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr. Rev. 22 (2001) 565-604
9. Heber D., Yip I., Ashley J.M., Elashoff D.A., Elashoff R.M., and Go V.L. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am. J. Clin. Nutr. 69 (1999) 231-236
10. Iismaa T.P., Kerr E.A., Wilson J.R., Carpenter L., Sims N., and Biden T.J. Quantitative and functional characterization of muscarinic receptor subtypes in insulin secreting cell lines and rat pancreatic islets. Diabetes 49 (2000) 392-398
11. Jeffcoate S.L. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet. Med. 21 (2004) 657-665
12. Journoud M., and Jones P.J. Red yeast rice: a new hypolipidemic drug. Life Sci. 74 (2004) 2675-2683
13. Kahn S.E. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J. Clin. Endocrinol. Metab. 86 (2001) 4047-4058
14. Korytkowski M.T. Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride. Pharmacotherapy 24 (2004) 606-620
15. Lindstrom J., Louheranta A., Mannelin M., Rastas M., Salminen V., Eriksson J., Uusitupa M., Tuomilehto J., and Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26 (2003) 3230-3236
16. Ma J., Li Y., Ye Q., Li J., Hua Y., Ju D., Zhang D., Cooper R., and Chang M. Constituents of red yeast rice, a traditional Chinese food and medicine. J. Agric. Food. Chem. 48 (2000) 5220-5225
17. Polonsky K.S., Pugh W., Jaspan J.B., Cohen D.M., Karrison T., Tager H.S., and Rubenstein A.H. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. J. Clin. Invest. 74 (1984) 1821-1829
18. Prado M.A., Gomez M.V., and Collier B. Mobilization of the readily releasable pool of acetylcholine from a sympathetic ganglion by tityustoxin in the presence of vesamicol. J. Neurochem. 59 (1992) 544-552
19. Tang S.H., and Sharp G.W. Identification of muscarinic receptor subtypes in RINm5F cells by means of polymerase chain reaction, subcloning, and DNA sequencing. Diabetes 46 (1997) 1419-1423
20. Wang J., Lu Z., Chi J., Wang W., Su M., Kou W., Vu P., Yu L., Chen L., Zhu J.S., and Chang J. Multicenter clinical trial of the serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Curr. Ther. Res. 58 (1997) 964-977
21. Zhao X. Effect of HC-3 on electroacupuncture-induced immunoregulation. Zhen. Ci. Yan. Jiu. 20 (1995) 59-62